Local injection of sgp130 into joints can significantly reduce the primary mechanical hyperalgesia and joint damage in the acute phase of AIA arthritis compared with repeated systemic injection of sgp130, but neither can reduce the secondary hyperalgesia [57]. The gene discussed is IL6ST; the disease is Arthritis.